Don't let the drug decide for you
FluoSphera is a Swiss biotech company developing a human multi-tissue platform for next-generation drug discovery. Its technology uses encapsulated organ-like microtissues to mimic systemic clinical drug responses, enabling high-throughput, human-relevant in vitro drug profiling before clinical trials. The company is headquartered in Geneva, Switzerland, with a US presence in Boston.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2026
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
